Skip to main content
logo
Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
15.91
+0.33 (2.12%)
At close: Jun 3, 2026, 4:00 PM EDT
15.92
+0.01 (0.06%)
After-hours: Jun 3, 2026, 4:01 PM EDT

Theravance Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
819956466541732823
Market Cap Growth
78.08%105.25%-13.88%-26.14%-11.02%-28.05%
Enterprise Value
461.41671.9416.28483.35449.771,301
Last Close Price
15.9118.719.4111.2411.2211.05
PE Ratio
7.179.08--0.95-
Forward PE
7.0925.83----
PS Ratio
7.438.897.239.4114.2514.87
PB Ratio
2.763.222.652.541.66-2.43
P/TBV Ratio
2.833.252.622.921.87-2.27
P/FCF Ratio
3.034.01----
P/OCF Ratio
3.034.01----
EV/Sales Ratio
4.206.256.478.428.7623.52
EV/EBITDA Ratio
70.17329.53----
EV/FCF Ratio
1.722.82----
Debt / Equity Ratio
0.100.110.220.210.10-1.93
Debt / EBITDA Ratio
-20.94----
Debt / FCF Ratio
0.150.18----
Net Debt / Equity Ratio
-1.22-0.92-0.22-0.25-0.62-1.46
Net Debt / EBITDA Ratio
27.32-133.720.941.073.27-1.99
Net Debt / FCF Ratio
-1.32-1.143.251.811.47-2.35
Asset Turnover
0.230.260.170.120.100.13
Quick Ratio
12.9110.734.894.8411.993.20
Current Ratio
13.1410.935.025.3912.314.26
Return on Equity (ROE)
51.57%54.73%-22.96%-15.05%-179.83%82.53%
Return on Assets (ROA)
-4.12%-0.86%-12.76%-11.33%-18.72%-61.06%
Return on Invested Capital (ROIC)
-18.93%-1.86%-18.42%-21.31%-43.41%-184.39%
Return on Capital Employed (ROCE)
-4.20%-0.94%-13.82%-11.97%-20.55%-77.91%
Earnings Yield
14.04%11.01%--105.61%-
FCF Yield
32.95%24.96%----
Buyback Yield / Dilution
-5.48%-5.45%11.67%24.85%-5.95%-11.41%
Total Shareholder Return
-5.48%-5.45%11.67%24.85%-5.95%-11.41%
SEC Filings: 10-K · 10-Q